참고문헌
- Hong SL, Kim SW, Won TB, Shim WS, Kim YM, Kim JW, et al. Clinical Features and Treatment Outcomes of Mucosal Malignant Melanomas of Nasal Cavity and Paranasal Sinuses. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 2006;49(12):1176-80.
- Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer: Interdisciplinary International Journal of the American Cancer Society 1998;83(8):1664-78.
- Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000;36(5):387-402. https://doi.org/10.1046/j.1365-2559.2000.00894.x
- Lian B, Guo J. Adjuvant therapy of mucosal melanoma. Chinese Clinical Oncology 2014;3(3):33.
- Snow G, Van Esch ED, Van Slooten E. Mucosal melanomas of the head and neck. Head & Neck Surgery 1978;1(1):24-30. https://doi.org/10.1002/hed.2890010104
- Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology 2010;17(6):1471-4. https://doi.org/10.1245/s10434-010-0985-4
- Koivunen P, Back L, Pukkila M, Laranne J, Kinnunen I, Grenman R, et al. Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma. The Laryngoscope 2012;122(8):1734-8. https://doi.org/10.1002/lary.23343
- Prasad ML, Patel S, Hoshaw-Woodard S, Stacy, Escrig, Margarita, Shah, Jatin P, et al. Prognostic factors for malignant melanoma of the squamous mucosa of the head and neck. The American Journal of Surgical Pathology 2002;26(7):883-92. https://doi.org/10.1097/00000478-200207000-00006
- Blessing K, Grant JJH, Sanders DSA, Kennedy MM, Husain A, Coburn P. Small cell malignant melanoma: a variant of naevoid melanoma. Clinicopathological features and histological differential diagnosis. Journal of Clinical Pathology. 2000;53(8):591-5. https://doi.org/10.1136/jcp.53.8.591
- Cocconi G, Bella M, Calabresi F, Tonato M, Canaletti R, Boni C, et al. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. New England Journal of Medicine 1992;327 (8):516-23. https://doi.org/10.1056/NEJM199208203270803
- Barth A, Morton DL. The role of adjuvant therapy in melanoma management. Cancer 1995;75(S2):726-34. https://doi.org/10.1002/1097-0142(19950115)75:2+<726::AID-CNCR2820751417>3.0.CO;2-R
- Garbe C, Peris K, Hauschild A, Hauschild A, Saiag P, Middleton M, et al. Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. European Journal of Cancer 2010;46(2):270-83. https://doi.org/10.1016/j.ejca.2009.10.032
- Coit DG, Thompson JA, Algazi A, Andtbacka R, Christopher K, Bichakjian, et al. Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network 2016;14(4):450-73. https://doi.org/10.6004/jnccn.2016.0051
- Verma S, Quirt I, McCready D, Bak K, Charette M, Iscoe N, et al. Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma. Cancer 2006;106(7):1431-42. https://doi.org/10.1002/cncr.21760
- Owens JM, Roberts DB, Myers JN. The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Archives of Otolaryngology-Head & Neck Surgery 2003;129(8):864-8. https://doi.org/10.1001/archotol.129.8.864
- 최병철 Issue& Trend 면역항암제; 2017. http://www.health.kr/Menu.PharmReview/_uploadfiles/%EB%A9%B4%EC%97%AD%ED%95%AD%EC%95%94%EC%A0%9C(Cancer%20Immunotherapy)%20(2).pdf. Accessed 2018.07.31.